Phamacokinetics and Safety Profiles of DA-5210 10/1000mg in Healthy Subjects at Fasting State
Clinical trial NCT05108571 · COMPLETED
Trial details
- NCT number
- NCT05108571
- Sponsor
- Dong-A ST Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-28
- Primary completion
- 2022-01-27
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.